Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
60.9K
-
Shares change
-
+1.73K
-
Total reported value, excl. options
-
$159K
-
Value change
-
+$4.51K
-
Number of buys
-
1
-
Price
-
$2.61
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2023
2 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q4 2023.
Summit Therapeutics Inc. - COM (SMMT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.9K shares
.
Largest 10 shareholders include BlackRock Inc. (9.76M shares), VANGUARD GROUP INC (7.01M shares), GEODE CAPITAL MANAGEMENT, LLC (3.09M shares), STATE STREET CORP (2.46M shares), NORTHERN TRUST CORP (1.11M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (954K shares), MORGAN STANLEY (704K shares), Steward Partners Investment Advisory, LLC (600K shares), Nuveen Asset Management, LLC (566K shares), and ALPS ADVISORS INC (532K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.